GeneReach Biotechnology Revenue

In the year 2024, GeneReach Biotechnology had annual revenue of 206.49M TWD, down -8.41%. GeneReach Biotechnology had revenue of 54.97M in the quarter ending December 31, 2024, with 0.26% growth.

Revenue

206.49M

Revenue Growth

-8.41%

P/S Ratio

5.51

Revenue / Employee

n/a

Employees

n/a

Market Cap

1.14B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	206.49M	-18.97M	-8.41%
Dec 31, 2023	225.46M	-524.56M	-69.94%
Dec 31, 2022	750.02M	-262.06M	-25.89%
Dec 31, 2021	1.01B	155.04M	18.09%
Dec 31, 2020	857.03M	491.24M	134.29%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	9.73B
Caliway Biopharmaceuticals	44.43M
Bora Pharmaceuticals Co., LTD.	19.25B
Lotus Pharmaceutical	18.58B
Polaris Group	107.00M
Oneness Biotech	117.93M
Lumosa Therapeutics	43.59M
Pegavision	6.82B

Revenue Rankings